Related Experiment Video
Updated: Jul 8, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Less-invasive and highly effective method for preventing methicillin-resistant Staphylococcus aureus graft infection
Hisashi Sakaguchi1, Akira Marui, Keiichi Hirose
1Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Objective:
Methicillin-resistant Staphylococcus aureus graft infection is one of the most serious complications of vascular surgery. Vancomycin is a potent antibiotic against methicillin-resistant S. aureus; however, systemic administration of vancomycin is not very effective against methicillin-resistant S. aureus graft infection. Therefore, we investigated whether a local sustained release of vancomycin prevents methicillin-resistant S. aureus graft infection.
Methods:
We have developed a poly-L-lactide-co-caprolactone sheet that enabled sustained release of vancomycin for 2 weeks. An expanded polytetrafluoroethylene vascular graft patch (1.5 mm2) was sutured at the anterior wall of the incised murine abdominal aorta. Methicillin-resistant S. aureus (1.0 x 10(3) colony-forming units) was inoculated onto the graft surface. Thereafter, the graft was treated as follows (n = 6 each): no treatment (control group), local injection of an aqueous solution of vancomycin (vancomycin solution group) and local implantation of poly-L-lactide-co-caprolactone containing vancomycin (vancomycin-PLCA group). After 7 days, the graft and blood were sampled and cultured.
Results:
The methicillin-resistant S. aureus counts in the grafts of the vancomycin-PLCA group were significantly lower than those of the other groups. Blood cultures of the vancomycin-PLCA group were all negative, whereas those of the other groups were all positive for infection. The survival rate in the vancomycin-PLCA group at 28 days was considerably higher than that in the control group (83.3% vs 16.7%).
Conclusions:
A local sustained-release sheet containing vancomycin reduced methicillin-resistant S. aureus counts in the infected vascular grafts, prevented sepsis, and drastically improved survival rates. This can be used as a highly effective and less-invasive adjunctive treatment method for preventing prosthetic methicillin-resistant S. aureus graft infection.
Insights
A novel vancomycin-eluting sheet effectively prevented methicillin-resistant Staphylococcus aureus graft infections in a murine model. This local sustained-release approach significantly reduced bacterial counts and improved survival rates.
Area of Science:
- Biomaterials Science
- Infectious Disease Research
- Vascular Surgery
Background:
- Prosthetic vascular graft infections, particularly by methicillin-resistant Staphylococcus aureus (MRSA), pose serious complications in vascular surgery.
- Systemic vancomycin administration shows limited efficacy against established MRSA graft infections.
- Developing localized treatment strategies is crucial for preventing and managing these infections.
Purpose of the Study:
- To investigate the efficacy of a locally sustained-release vancomycin-eluting poly-L-lactide-co-caprolactone (PLCA) sheet in preventing MRSA vascular graft infections.
- To evaluate the impact of this localized treatment on bacterial load, sepsis development, and survival rates.
Main Methods:
- Development of a PLCA sheet for sustained vancomycin release over two weeks.
- Suturing of expanded polytetrafluoroethylene vascular graft patches onto murine aortas.
- Inoculation of MRSA onto grafts, followed by treatment with no intervention, vancomycin solution, or vancomycin-PLCA sheet.
- Post-treatment assessment of graft bacterial counts, blood cultures, and survival rates at 7 and 28 days.
Main Results:
- The vancomycin-PLCA group exhibited significantly lower MRSA counts in grafts compared to control and vancomycin solution groups.
- All blood cultures in the vancomycin-PLCA group were negative for infection, while others were positive.
- Survival rates at 28 days were substantially higher in the vancomycin-PLCA group (83.3%) versus the control group (16.7%).
Conclusions:
- Local sustained release of vancomycin via a PLCA sheet effectively reduces MRSA in infected vascular grafts.
- This localized treatment prevents sepsis and significantly improves survival rates in a murine model.
- The vancomycin-PLCA sheet represents a promising, less-invasive adjunctive therapy for preventing prosthetic MRSA graft infections.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia
Local Anesthetics: Pharmacokinetics
